Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meilan Liu

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Research Communications|November 16, 2022
Bcl-xL inhibition radiosensitizes <i>PIK3CA/PTEN</i> wild-type triple negative breast cancers with low Mcl-1 expressionAndrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
Frontiers in Endocrinology|March 3, 2020
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer CellsAnna R Michmerhuizen, Benjamin Chandler, Eric Olsen, et al.
NPJ Breast Cancer|March 11, 2022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer modelsAnna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, et al.
Molecular Cancer Research : MCR|July 18, 2014
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancerRohit Malik, Lalit Patel, John R Prensner, et al.
Genomics, Proteomics & Bioinformatics|April 1, 2020
Tung Tree (Vernicia fordii) Genome Provides A Resource for Understanding Genome Evolution and Improved Oil ProductionLin Zhang, Meilan Liu, Hongxu Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
NPJ Breast Cancer|February 24, 2026
Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibitionBreanna McBean, Benjamin Hauk, Anna R Michmerhuizen, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Research Communications|November 16, 2022
Bcl-xL inhibition radiosensitizes <i>PIK3CA/PTEN</i> wild-type triple negative breast cancers with low Mcl-1 expressionAndrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
Frontiers in Endocrinology|March 3, 2020
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer CellsAnna R Michmerhuizen, Benjamin Chandler, Eric Olsen, et al.
NPJ Breast Cancer|March 11, 2022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer modelsAnna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, et al.
Molecular Cancer Research : MCR|July 18, 2014
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancerRohit Malik, Lalit Patel, John R Prensner, et al.
Genomics, Proteomics & Bioinformatics|April 1, 2020
Tung Tree (Vernicia fordii) Genome Provides A Resource for Understanding Genome Evolution and Improved Oil ProductionLin Zhang, Meilan Liu, Hongxu Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
NPJ Breast Cancer|February 24, 2026
Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibitionBreanna McBean, Benjamin Hauk, Anna R Michmerhuizen, et al.
The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.
Pageof 7